Skip to main content
. 2020 Jul 17;25(14):3255. doi: 10.3390/molecules25143255

Table 1.

Synergetic activity of rifampicin and vancomycin with tridecaptin M against Gram-negative bacteria.

Strain Tri-M MIC (µg/mL) Antibiotic Tri-M Concentration
(µg/mL)
MIC (µg/mL) Potentiation Factor FICI
A. baumannii
ATCC 19606
32 Vancomycin 0 128
2 128 1 -
4 32 4 0.375
8 8 16 0.312
Rifampicin 0 4
2 2 2 0.562
4 1 4 0.375
8 0.25 16 0.312
K. pneumoniae
ATCC 700603
4 Vancomycin 0 128
0.25 128 1 -
0.5 128 1 -
1.0 128 1 -
Rifampicin 0 32
0.25 32 1 -
0.5 32 1 -
1.0 32 1 -
P. aeruginosa
ATCC 27853
256 Vancomycin 0 256
4 256 1 -
8 256 1 -
16 256 1 -
Rifampicin 0 64
4 32 2 0.515
8 32 2 0.531
16 32 2 0.562

Tri-M—tridecaptin M; FICI—fractional inhibitory concentration index. FICI of ≤0.5 was considered as synergy. (-) represents no change in MIC, and hence, FICI was not calculated for these.